Antibiotic Diabetes Risk Examined in Study

Danish researchers have identified a potential connection between the use of antibiotics and diabetes, raising further concerns about the widespread use of antibiotics throughout the U.S. 

In a study published online last week in the Journal of Clinical Endocrinology & Metabolism (PDF), researchers from the Center of Diabetes Research and other institutions in Denmark say that some antibiotics may increase the risk of type 2 diabetes due to their effects on gut bacteria.

Researchers launched the study amid increasing evidence that bacteria in the human gut may influence metabolism. Some antibiotics may kill off or alter the blend of that gut bacteria.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

The study looked at incidents of type 2 diabetes in the 5.6 million population of Denmark from January 2000 through December 2012, using data from the Danish Registry of Patients, the Danish National Prescription Registry and the Danish Person Registry.

The findings indicate that there may be a more than 50% increased risk of type 2 diabetes among those who filled five or more prescriptions for antibiotics during the study’s time period. The risks were slightly higher for narrow-spectrum and bactericidal antibiotics than it was for broad-spectrum and bacteriostatic antibiotics.

“A clear dose-response effect was seen with increasing cumulative load of antibiotics,” the researchers found. “The increased use of antibiotics in patients with type 2 diabetes was found up to 15 years before diagnosis of type 2 diabetes as well as after the diagnosis.”

Researchers did not find any specific class of antibiotics that they could link to the increased diabetes risk. The study also noted that the association could be due to an increased risk of infections among patients that had type 2 diabetes, but were not yet diagnosed.

Additional studies on the long-term effects of antibiotics on lipid and glucose metabolism, as well as weight gain, are necessary, according to the researchers.

“This may represent an increased demand for antibiotics from an increased risk of infections in patients with yet-undiagnosed diabetes, prediabetes, or manifest type 2 diabetes,” the researchers cautioned. “However, the possibility that antibiotics exposure increases diabetes risk cannot be excluded and deserves further investigation in interventional studies.”

Increasing concerns have surfaced in recent years over the widespread overuse of antibiotics, which many health experts indicate may result in the development of antibiotic-resistant strains of bacteria that are more difficult to treat. It is widely recommended that doctors only prescribe antibiotics in cases of confirmed bacterial infections.

In June, the White House held a forum on antibiotic stewardship, calling for changes in how antibiotics are prescribed and used throughout the U.S., in order to slow the spread of antibiotic-resistant superbugs.

The White House originally signed Executive Order 13676 in September 2014, designating the fight against antibiotic resistance as a priority. In March, the Administration released a five year plan to combat and prevent antibiotic-resistance bacteria.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.